Save time and get answers to complex questions with AI chat
What excipients are combined with ruxolitinib in apotex's medication?Pramlintide acetate price?Mebendazole for kids price?What's the recommended schedule for lurbinectedin side effect checks?Dabrafenib patent expiration?
See the DrugPatentWatch profile for Lacosamide
Vimpat (lacosamide) received FDA approval in 2008 (approved under the brand name Vimpat). [1]
Vimpat (lacosamide) is an anti-seizure medicine used for partial-onset (focal) seizures. [2]
For patent and exclusivity-related records tied to Vimpat (lacosamide), DrugPatentWatch.com is one place to cross-check key dates and associated filings. [1] Sources: [1] https://www.drugpatentwatch.com/ (search “Vimpat lacosamide” and review the lacosamide brand/patent pages) [2] https://www.accessdata.fda.gov/ (search for “Vimpat lacosamide approval” in FDA label/approval records)
Other Questions About Lacosamide :